Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP750642.RAfotPglhaX3cMRO_MGkLYM9L6KYivt-N0wdDTM7IXbbg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP750642.RAfotPglhaX3cMRO_MGkLYM9L6KYivt-N0wdDTM7IXbbg130_assertion type Assertion NP750642.RAfotPglhaX3cMRO_MGkLYM9L6KYivt-N0wdDTM7IXbbg130_head.
- NP750642.RAfotPglhaX3cMRO_MGkLYM9L6KYivt-N0wdDTM7IXbbg130_assertion description "[Cenersen, an oligonucleotide targeting TP53, has been shown to abrogate the activity of TP53 gain-of-function mutants and to increase sensitivity of lymphoma cells to cytotoxic chemotherapy in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP750642.RAfotPglhaX3cMRO_MGkLYM9L6KYivt-N0wdDTM7IXbbg130_provenance.
- NP750642.RAfotPglhaX3cMRO_MGkLYM9L6KYivt-N0wdDTM7IXbbg130_assertion evidence source_evidence_literature NP750642.RAfotPglhaX3cMRO_MGkLYM9L6KYivt-N0wdDTM7IXbbg130_provenance.
- NP750642.RAfotPglhaX3cMRO_MGkLYM9L6KYivt-N0wdDTM7IXbbg130_assertion SIO_000772 21827374 NP750642.RAfotPglhaX3cMRO_MGkLYM9L6KYivt-N0wdDTM7IXbbg130_provenance.
- NP750642.RAfotPglhaX3cMRO_MGkLYM9L6KYivt-N0wdDTM7IXbbg130_assertion wasDerivedFrom befree-20150227 NP750642.RAfotPglhaX3cMRO_MGkLYM9L6KYivt-N0wdDTM7IXbbg130_provenance.
- NP750642.RAfotPglhaX3cMRO_MGkLYM9L6KYivt-N0wdDTM7IXbbg130_assertion wasGeneratedBy ECO_0000203 NP750642.RAfotPglhaX3cMRO_MGkLYM9L6KYivt-N0wdDTM7IXbbg130_provenance.